Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1786 AL 1800

Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia

Wang R, Holsinger RMD.

Ageing Res Rev. 2018 Dec;48:109-121. doi: 10.1016/j.arr.2018.10.002. Epub 2018 Oct 13.

Alzheimer Disease

Morley JE, Farr SA, Nguyen AD.

Clin Geriatr Med. 2018 Nov;34(4):591-601. doi: 10.1016/j.cger.2018.06.006. Epub 2018 Aug 21.

Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients

Zhang N, Gordon ML.

Clin Interv Aging. 2018 Oct 11;13:1963-1970. doi: 10.2147/CIA.S159920. eCollection 2018.

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease

Novak P, Schmidt R, Kontsekova E, Kovacech B, Smolek T, Katina S, Fialova L, Prcina M, Parrak V, Dal-Bianco P, Brunner M, Staffen W, Rainer M, Ondrus M, Ropele S, Smisek M, Sivak R, Zilka N, Winblad B, Novak M.

Alzheimers Res Ther. 2018 Oct 24;10(1):108. doi: 10.1186/s13195-018-0436-1.

Essential Oils as Treatment Strategy for Alzheimer's Disease: Current and Future Perspectives

Benny A, Thomas J.

Planta Med. 2019 Feb;85(3):239-248. doi: 10.1055/a-0758-0188. Epub 2018 Oct 25.

Effects of Acute and Chronic Exercise on Immunological Parameters in the Elderly Aged: Can Physical Activity Counteract the Effects of Aging?

Sellami M, Gasmi M, Denham J, Hayes LD, Stratton D, Padulo J, Bragazzi N.

Front Immunol. 2018 Oct 10;9:2187. doi: 10.3389/fimmu.2018.02187. eCollection 2018.

Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer's Disease

Wolinsky D, Drake K, Bostwick J.

Curr Psychiatry Rep. 2018 Oct 27;20(12):117. doi: 10.1007/s11920-018-0978-8.

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease

Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H.

Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24.

Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study

Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen AM.

J Am Heart Assoc. 2018 Sep 18;7(18):e009742. doi: 10.1161/JAHA.118.009742.

Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology

Uddin MS, Al Mamun A, Kabir MT, Jakaria M, Mathew B, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Jul;56(7):4925-4944. doi: 10.1007/s12035-018-1420-2. Epub 2018 Nov 9.

The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease

Lu MH, Zhao XY, Yao PP, Xu DE, Ma QH.

Neurosci Bull. 2018 Dec;34(6):1127-1130. doi: 10.1007/s12264-018-0310-y. Epub 2018 Nov 12.

Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review

Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y.

Clin Interv Aging. 2018 Oct 18;13:2061-2073. doi: 10.2147/CIA.S184968. eCollection 2018.

Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease

Silva CFM, Pinto DCGA, Silva AMS.

Expert Opin Drug Discov. 2018 Dec;13(12):1141-1151. doi: 10.1080/17460441.2018.1543267. Epub 2018 Nov 15.

Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease

Morsy A, Trippier PC.

J Med Chem. 2019 May 9;62(9):4252-4264. doi: 10.1021/acs.jmedchem.8b01530. Epub 2018 Nov 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias